What is the purpose of the Cost-Effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients with Heart Failure and Reduced Ejection Fraction?
The purpose of the Cost-Effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients with Heart Failure and Reduced Ejection Fraction is to compare the two treatments in terms of effectiveness, safety, and cost-effectiveness. This analysis will help to determine which of the two treatments is most appropriate for patients with this condition, and can inform healthcare decision-making. The analysis may also provide insight into the cost-effectiveness of disease management strategies for this condition. 